Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Copenhagen Doctors Aps Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   11.1% 10.5% 5.9% 3.6% 2.6% 3.1% 15.7% 15.7%   Credit score (0-100)   23 23 38 52 60 57 12 12   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,108 1,550 2,263 2,530 2,789 2,805 0.0 0.0   EBITDA   328 -151 417 466 539 350 0.0 0.0   EBIT   247 -201 353 357 367 212 0.0 0.0   Pre-tax profit (PTP)   242.9 -202.8 339.7 350.5 347.7 196.6 0.0 0.0   Net earnings   185.6 -161.6 263.3 260.4 271.0 146.9 0.0 0.0   Pre-tax profit without non-rec. items   243 -203 340 351 348 197 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   40.5 194 405 596 679 541 0.0 0.0   Shareholders equity total   223 38.5 302 462 615 640 305 305   Interest-bearing liabilities   0.0 0.0 38.8 54.8 195 156 0.0 0.0   Balance sheet total (assets)   421 353 860 1,028 1,323 1,398 305 305   Net Debt   -195 -24.6 -165 -230 -295 -423 -305 -305     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,108 1,550 2,263 2,530 2,789 2,805 0.0 0.0   Gross profit growth   3.3% -26.5% 46.0% 11.8% 10.3% 0.6% -100.0% 0.0%   Employees   2 2 3 3 3 3 0 0   Employee growth %   100.0% 0.0% 50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   421 353 860 1,028 1,323 1,398 305 305   Balance sheet change%   -21.6% -16.1% 143.4% 19.6% 28.7% 5.7% -78.2% 0.0%   Added value   327.6 -151.1 416.8 465.9 475.3 350.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -230 103 147 83 -89 -277 -541 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.7% -13.0% 15.6% 14.1% 13.2% 7.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   51.5% -52.0% 58.2% 37.9% 31.2% 15.6% 0.0% 0.0%   ROI %   114.1% -154.1% 186.2% 67.3% 47.2% 25.7% 0.0% 0.0%   ROE %   142.4% -123.6% 154.8% 68.2% 50.3% 23.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   53.0% 10.9% 35.1% 45.0% 46.5% 45.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -59.5% 16.3% -39.6% -49.4% -54.7% -120.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 12.9% 11.9% 31.6% 24.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 0.0% 67.8% 14.6% 15.4% 8.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.9 0.5 0.8 1.2 1.2 1.3 0.0 0.0   Current Ratio   1.9 0.5 0.8 1.2 1.2 1.3 0.0 0.0   Cash and cash equivalent   194.8 24.6 203.9 284.8 489.2 578.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   182.6 -157.5 -105.1 67.6 97.0 216.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   164 -76 139 155 158 117 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   164 -76 139 155 180 117 0 0   EBIT / employee   123 -101 118 119 122 71 0 0   Net earnings / employee   93 -81 88 87 90 49 0 0